Immunoglobulin Market Growth and Industry Revenue By Top Key Players Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, Bayer Healthcare & Many Others

Global Immunoglobulin Market was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR of 7.3% from 2017 to 2023.

Immunoglobulin is a protein produced by plasma cells and other lymphocytes. They are highly complex entities that exert their immunomodulatory effect on the different components of the immune system. They are obtained from blood by fractionation process and purified for therapeutic and non-therapeutic applications. Different classes of immunoglobulin such as IgG, IgA, and IgM are used for the treatment of various immunological and neurological diseases. These immunoglobulins can be administered intravenously and subcutaneously.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2586

The major factors that fuel the market growth during the forecast period include increase in geriatric population & number of hemophilic patients, improved immunoglobulin production owing to the emergence of advanced technologies, and enhanced purification techniques (with better plasma yield). Furthermore, surge in prevalence diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia & others are expected to boost the market growth. However, stringent government regulations toward immunoglobulin products and high risk of side effects owing to the use of immunoglobulin are expected to hamper the growth of the market.

The key companies profiled in the report include

• Baxter international Inc.,
• CSL Ltd,
• Grifols S.A,
• Octapharma AG,
• Kedrion Biopharma Inc.,
• LFB group,
• Biotest AG,
• China Biologics Products Inc.,
• BDI Pharma Inc., and
• Bayer Healthcare.

In 2016, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.

Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.

Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market. However, high costs associated with the immunoglobulin treatment; shortage of immunoglobulin; and side effects of immunoglobulin treatment such as headache, migraine, fever, nausea or vomiting, and cough hinder the market growth. Immunoglobulin products are widely used for the treatment of immunodeficiency disease, ITP, chronic lymphocytic leukemia (CLL), and others. Rise in geriatric population, increase in patient population of blood disorders, and high healthcare expenditure are anticipated to boost the market growth.

Get More Information @ https://www.alliedmarketresearch.com/connect-to-analyst/2586

Key Findings of the Immunoglobulin Market:

• Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
• Hypogammaglobulinemia was the highest revenue-generating segment, and is expected to continue its dominance in future.
• North America dominated global immunoglobulins market, and is projected to grow at a CAGR of 7.0% in terms of value.
• Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 11.8%. in terms of value.
• LAMEA segment was the fastest growing segment growing at a CAGR of 10.6% in terms of volume.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW OF IMMUNOGLOBULIN
3.2.1. Patented products
3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHRONIC CONDITIONS
3.4. COST OF SIDE EFFECTS OF IMMUNOGLOBULIN TREATMENT
3.5. KEY FINDINGS
3.5.1. Top factors impacting
3.5.2. Top investment pockets
3.6. PORTER’S FIVE FORCES ANALYSIS
3.7. VALUE CHAIN ANALYSIS
3.7.1. Primary activities
3.7.2. Support activities
3.8. MARKET SHARE ANALYSIS, 2016
3.9. PRODUCT SCENARIO IN IMMUNOGLOBULIN MARKET
3.10. GOVERNMENT REGULATIONS AND REIMBURSEMENTS
3.10.1. U.S.
3.10.2. Europe
3.10.2.1. France
3.10.2.2. Germany
3.10.2.3. Italy
3.10.3. China
3.10.4. Japan
3.10.5. India
3.11. INDICATIONS FOR IMMUNOGLOBULIN
3.11.1. U.S. FDA indications
3.11.2. EMA
3.12. COMPONENT ANALYSIS OF IMMUNOGLOBULIN G (IGG)
3.12.1. IgG1
3.12.2. IgG2
3.12.3. IgG3
3.12.4. IgG4
3.13. CLINICAL TRIALS
3.14. MARKET DYNAMICS
3.14.1. Drivers
3.14.1.1. Rise in prevalence of immunodeficiency diseases
3.14.1.2. Increase in adoption of immunoglobulin
3.14.1.3. Increase in incidence of bleeding disorders
3.14.1.4. Surge in geriatric population
3.14.2. Restraints
3.14.2.1. Stringent government regulations
3.14.2.2. High cost of therapy
3.14.3. Opportunities
3.14.3.1. Opportunities in emerging economies
3.14.3.2. Development of cost-effective therapeutics through large-scale production

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/immunoglobulin-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.